Evan R. Lewis
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 5%
- Hematology top 5%
- Cell Biology top 5%
- Co-authors
- Mark K. BennettFrancesco ParlatiSusan D. DemoGuy J. LaidigMirna L.M. RodriguezJulie JanesJinfu YangFrances Zhao
- Topics
- Multiple Myeloma Research and Treatments (5 papers)Ubiquitin and proteasome pathways (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyBlood
- Partner nations
- United StatesBelgium
In The Last Decade
Evan R. Lewis
19 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.3k
- Cancer Research 701
- Oncology 467
- Hematology 288
- Cell Biology 221
Countries citing papers authored by Evan R. Lewis
This map shows the geographic impact of Evan R. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan R. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan R. Lewis more than expected).
Fields of papers citing papers by Evan R. Lewis
This network shows the impact of papers produced by Evan R. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan R. Lewis. The network helps show where Evan R. Lewis may publish in the future.
Co-authorship network of co-authors of Evan R. Lewis
This figure shows the co-authorship network connecting the top 25 collaborators of Evan R. Lewis. A scholar is included among the top collaborators of Evan R. Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan R. Lewis. Evan R. Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancerbreakdown → | 797 |
| 2 | 7 | |
| 3 | 12 | |
| 4 | 21 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 10 | |
| 9 | Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasomebreakdown → | 542 |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 215 | |
| 13 | 60 | |
| 14 | 22 | |
| 15 | 50 | |
| 16 | 23 | |
| 17 | 48 | |
| 18 | 81 | |
| 19 | 49 | |
| 20 | 23 |
About Evan R. Lewis
Evan R. Lewis is a scholar working on Molecular Medicine, Hematology and Biochemistry, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (701 citations), Hematology (288 citations) and Biochemistry (148 citations). Evan R. Lewis has collaborated with scholars based in United States and Belgium. Frequent co-authors include Mark K. Bennett, Francesco Parlati, Susan D. Demo, Guy J. Laidig, Mirna L.M. Rodriguez, Julie Janes, Jinfu Yang, Frances Zhao, Peter J. Shwonek and Taotao Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.